Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
Fujirebio Europe Receives Translational Research Funding From Alzheimer’S Drug Discovery Foundation For Development Of A Fully Automated Plasma Ptau181 Testing Solution
Fujirebio Europe Receives Translational Research Funding From Alzheimer’S Drug Discovery Foundation For Development Of A Fully Automated Plasma Ptau181 Testing Solution
Company Info
Company news
Wed, 25 Sep 2024 07:00:00 GMT
Fujirebio Submits FDA Regulatory Filing for Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease - Business Wire
Mon, 23 Dec 2024 08:00:00 GMT
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases - Business Wire
Mon, 15 Jul 2024 07:00:00 GMT
AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Milestone Achievement to Advance Biomarker Development for Alzheimer’s Disease and Neurodegeneration - Yahoo Finance
Tue, 12 Mar 2024 07:00:00 GMT
Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics - PR Newswire
Wed, 14 Feb 2024 08:00:00 GMT
Abbott and Fujirebio work on neurological biomarker assay for researchers - Medical Design & Outsourcing
Fri, 26 Jul 2024 07:00:00 GMT
Fujirebio Launches the Fully Automated Lumipulse® G GFAP Assay for Research Use Only and Further Strengthens its Neuro Test Menu - Yahoo Finance
Wed, 11 Sep 2024 07:00:00 GMT
Agappe Diagnostics, Fujirebio Holdings forge alliance to develop diagnostic tools - BusinessLine
Tue, 18 Jul 2023 07:00:00 GMT
Beckman Coulter, Fujirebio partner on gold rush for Alzheimer's blood tests - Fierce Biotech
Mon, 17 Jul 2023 07:00:00 GMT
Beckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer's Disease Test - PR Newswire
Wed, 08 Mar 2023 08:00:00 GMT
AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Strategic Partnership to Advance Biomarker Development for Alzheimer’s Disease and Neurodegeneration - Business Wire
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.